Xiling Lab

Xiling Lab covers full chain of pharmaceutical industry with strong background and robust capabilities. We specialize in innovative XDC platform technology (especially linker-drug systems and conjugation technology) and highly complex generic products (oncology & contrast media, star products include Eribulin Mesylate Injection and APIs of Eribulin Mesylate, Lurbinectedin, Trabectedin, Gadobutrol, Deucravacitinib, Rimegepant Sulfate). With our excellent synthetic process and unique catalytic technology, we not only have the capability for large-batch production but also ensure outstanding quality and effective cost control, which means we can offer more benefits to our partners.